Aditya Shreenivas MD MS

21 posts

Aditya Shreenivas MD MS

Aditya Shreenivas MD MS

@AdityaSunavs

Assistant Professor Medical Oncology City of Hope Comprehensive Cancer Center

Duarte, CA Katılım Eylül 2014
610 Takip Edilen271 Takipçiler
Sumanta K. Pal, MD, FASCO
Sumanta K. Pal, MD, FASCO@montypal·
Huge congrats to our @cityofhope star faculty @AdityaSunavs who presented the phase III AK105-304 study in an oral session at #AACR25, a study leading to @US_FDA approval of penpulimab-kcqx in #nasopharyngeal cancer!
Sumanta K. Pal, MD, FASCO tweet media
Aditya Shreenivas MD MS@AdityaSunavs

We have another option to treat R/M Nasopharyngeal carcinoma. Honored to have presented AK105-304 phase III study at AACR. Special thanks to Akesobio team, City of Hope, all investigators and most importantly all pts. who contributed to this study. Stay tuned more to come!!

English
1
11
29
4.1K
Aditya Shreenivas MD MS
Aditya Shreenivas MD MS@AdityaSunavs·
We have another option to treat R/M Nasopharyngeal carcinoma. Honored to have presented AK105-304 phase III study at AACR. Special thanks to Akesobio team, City of Hope, all investigators and most importantly all pts. who contributed to this study. Stay tuned more to come!!
Aditya Shreenivas MD MS tweet mediaAditya Shreenivas MD MS tweet mediaAditya Shreenivas MD MS tweet mediaAditya Shreenivas MD MS tweet media
English
2
7
15
4.8K
Aditya Shreenivas MD MS retweetledi
Razelle Kurzrock, MD
Razelle Kurzrock, MD@Dr_R_Kurzrock·
Hear ye hear ye! FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive solid tumors | FDA Her2 3+ 👉🔥🎯If it’s a marker, it’s a pan cancer marker: Tissue is not the issue fda.gov/drugs/resource…
English
2
23
88
6.6K
Aditya Shreenivas MD MS retweetledi
City of Hope
City of Hope@cityofhope·
Dr. David Craig joins the "Transcriptomics in Precision Oncology" panel chaired by @Dr_R_Kurzrock. Don't miss his insights on opportunities and limitations in this field and a deep dive into his favorite topic at #PMWC24: pmwcintl.com/session/jan-24…
City of Hope tweet media
English
0
3
6
1.8K
Aditya Shreenivas MD MS retweetledi
Sewanti Limaye 🇮🇳🇺🇸
Sewanti Limaye 🇮🇳🇺🇸@SewantiLimaye·
So amazing to meet you again Ray @Dr_R_Kurzrock You are the inspiration that keeps us going every day! 🙏🤗🌺 @AdityaSunavs
Razelle Kurzrock, MD@Dr_R_Kurzrock

Special moments. Look whom I found in Milwaukee at MCW. Sewanti Limaye and her brother Aditya Shreeenivas— amongst the best precision oncologists on the planet. Aditya’s wife just had a beautiful baby boy— hence the visit from Sewanti all the way from India!

English
1
4
15
1.4K
Aditya Shreenivas MD MS retweetledi
Razelle Kurzrock, MD
Razelle Kurzrock, MD@Dr_R_Kurzrock·
If it’s a target, it’s a pan-cancer target: Tissue is not the issue If it’s a solid tumor target, it’s a heme target (& vice versa) See our new review 🎯🎯 Illustrative case: Erdheim Chester disease (non-Langerhans histiocytosis)/CNS disease/ALK fusion->Alectinib response
Razelle Kurzrock, MD tweet media
English
0
14
40
6.3K
Aditya Shreenivas MD MS retweetledi
Timothy Chan
Timothy Chan@GeneCollector·
We then used machine learning with a random forest approach to build a model trained off of radiographic response (not survival). Training off response outcomes can help control for the many confounding factors that can affect overall survival
Timothy Chan tweet media
English
1
1
16
0
Aditya Shreenivas MD MS retweetledi
Razelle Kurzrock, MD
Razelle Kurzrock, MD@Dr_R_Kurzrock·
This may be a game changer. FDA Grants Breakthrough Device Designation for Biological Dynamics’ Early-stage Pancreatic Cancer Detection Test – San Diego Biotechnology Network businesswire.com/news/home/2021…
English
1
10
29
0

Keşfet

@montypal @cityofhope @US_FDA @DrRaviSalgia @TDorffOnc @VivekSubbiah @DrEzraCohen @eevokes